Furthermore, complete ablation or constitutive overexpression of transcription factors with tumour-suppressor functions (e.g. BLIMP1 (216)) or oncogenic potential (e.g. BATF3 (185, 217)) may be dangerous in modifying a cellular product. The gene discussed is PRDM1; the disease is neoplasm.